A single centre experience of patients with rare cancers referred for early phase clinical trials

Abstract Background Cancers affecting < 6/100,000/year are classified as rare, but they account for up to 25% of all cancers and are associated with worse 5-year survival than common cancers. Early-phase clinical trials (EPCTs) may represent a viable treatment option for patients with rare cancers a...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Angelos Angelakas, Natalie Cook, Donna M. Graham, Matthew Krebs, Fiona Thistlethwaite, Louise Carter
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMC 2025-03-01
Serie:	BMC Cancer
Ämnen:	Rare cancers Early phase trials Real world data Prognosis Precision medicine Molecular profiling
Länkar:	https://doi.org/10.1186/s12885-025-13934-2
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!